Moftakhar Leila, Rezaeianzadeh Ramin, Ghoddusi Johari Masoumeh, Hosseini Seyed Vhid, Rezaianzadeh Abbas
Student Research Committee Shiraz University of Medical Sciences Shiraz Iran.
Experimental Medicine Program, Department of Medicine, Faculty of Medicine University of British Columbia Vancouver British Columbia Canada.
Health Sci Rep. 2022 Dec 8;6(1):e988. doi: 10.1002/hsr2.988. eCollection 2023 Jan.
Multimorbidity is one of the problems and concerns of public health. The aim of this study was to estimate the prevalence and identify the risk factors associated with multimorbidity based on the data of the Kherameh cohort study.
This cross-sectional study was performed on 10,663 individuals aged 40-70 years in the south of Iran in 2015 to 2017. Demographic and behavioral characteristics were investigated. Multimorbidity was defined as the coexistence of two or more of two chronic diseases in a person. In this study, the prevalence of multimorbidity was calculated. Logistic regression was used to identify the predictors of multimorbidity.
The prevalence of multimorbidity was 24.4%. The age-standardized prevalence rate was 18.01% in males and 29.6% in females. The most common underlying diseases were gastroesophageal reflux disease with hypertension (33.5%). Multiple logistic regression results showed that the age of 45-55 years (adjusted odds ratio [OR] = 1.22, 95% confidence interval [CI], 1.07-1.38), age of over 55 years (OR = 1.21, 95% CI, 1.06-1.37), obesity (OR = 3.65, 95% CI, 2.55-5.24), and overweight (OR = 2.92, 95% CI, 2.05-4.14) were the risk factors of multimorbidity. Also, subjects with high socioeconomic status (OR = 1.27, 95% CI, 1.1-1.45) and very high level of socioeconomic status (OR = 1.53, 95% CI, 1.31-1.79) had a higher chance of having multimorbidity. The high level of education, alcohol consumption, having job, and high physical activity had a protective role against it.
The prevalence of multimorbidity was relatively high in the study area. According to the results of our study, age, obesity, and overweight had an important effect on multimorbidity. Therefore, determining interventional strategies for weight loss and control and treatment of chronic diseases, especially in the elderly, is very useful.
多病共存是公共卫生领域的问题与关注点之一。本研究旨在基于凯拉梅赫队列研究的数据估算多病共存的患病率,并确定与之相关的风险因素。
这项横断面研究于2015年至2017年在伊朗南部对10663名年龄在40 - 70岁的个体进行。调查了人口统计学和行为特征。多病共存定义为一个人同时患有两种或更多种慢性疾病。在本研究中,计算了多病共存的患病率。采用逻辑回归来确定多病共存的预测因素。
多病共存的患病率为24.4%。年龄标准化患病率男性为18.01%,女性为29.6%。最常见的基础疾病是胃食管反流病合并高血压(33.5%)。多项逻辑回归结果显示,45 - 55岁(调整后的比值比[OR]=1.22,95%置信区间[CI],1.07 - 1.38)、55岁以上(OR = 1.21,95% CI,1.06 - 1.37)、肥胖(OR = 3.65,95% CI,2.55 - 5.24)和超重(OR = 2.92,95% CI,2.05 - 4.14)是多病共存的风险因素。此外,社会经济地位高(OR = 1.27,95% CI,1.1 - 1.45)和社会经济地位非常高(OR = 1.53,95% CI,1.31 - 1.79)的受试者患多病共存的几率更高。高学历、饮酒、有工作和高体力活动对其有保护作用。
研究区域内多病共存的患病率相对较高。根据我们的研究结果,年龄、肥胖和超重对多病共存有重要影响。因此,确定减肥、控制体重以及治疗慢性疾病的干预策略,尤其是针对老年人,非常有用。